Atb Cap Markets Predicts Organigram FY2027 Earnings

Organigram Holdings Inc. (NASDAQ:OGI) – Analysts at Atb Cap Markets issued their FY2027 earnings per share (EPS) estimates for shares of Organigram in a research report issued on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes anticipates that the company will post earnings per share of $0.06 for the year. The consensus estimate for Organigram’s current full-year earnings is ($0.09) per share. Atb Cap Markets also issued estimates for Organigram’s FY2028 earnings at $0.14 EPS.

Organigram (NASDAQ:OGI) last announced its quarterly earnings results on Tuesday, February 11th. The company reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.02). Organigram had a negative return on equity of 11.68% and a negative net margin of 28.58%.

Organigram Stock Performance

NASDAQ:OGI opened at $1.35 on Thursday. The company has a 50-day moving average price of $1.56 and a 200-day moving average price of $1.67. The stock has a market cap of $170.32 million, a price-to-earnings ratio of -3.55 and a beta of 1.00. Organigram has a 12 month low of $1.29 and a 12 month high of $2.91.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Toronto Dominion Bank boosted its holdings in shares of Organigram by 803.7% during the 3rd quarter. Toronto Dominion Bank now owns 16,727 shares of the company’s stock valued at $30,000 after buying an additional 14,876 shares in the last quarter. Tidal Investments LLC lifted its position in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock valued at $3,526,000 after acquiring an additional 149,171 shares during the period. Clear Harbor Asset Management LLC boosted its stake in Organigram by 37.4% during the fourth quarter. Clear Harbor Asset Management LLC now owns 45,000 shares of the company’s stock worth $72,000 after acquiring an additional 12,250 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in Organigram in the fourth quarter worth about $1,153,000. Finally, Renaissance Technologies LLC increased its stake in shares of Organigram by 2.4% during the fourth quarter. Renaissance Technologies LLC now owns 914,648 shares of the company’s stock valued at $1,473,000 after purchasing an additional 21,200 shares in the last quarter. Hedge funds and other institutional investors own 34.63% of the company’s stock.

About Organigram

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.